Program: MCDC
Solicitation Number: TBD
Customer: DTRA RD-CBM
Release Date: Q4FY24
Description: The prioritizations on broad-spectrum direct-acting antivirals (nucleoside/nucleotide-like compounds and combination therapies) and host-directed broad-spectrum antivirals and antibacterials such as molecules that target host signaling pathways, are involved in entry and replication, epigenetic modifications in the host, and modulation of host response.
upcoming_solicitations
solicitation_program: MCDC
solicitation_number: TBD
solicitation_customer: DTRA RD-CBM
solicitation_anticipated_release_date: Q4FY24
solicitation_description: The prioritizations on broad-spectrum direct-acting antivirals (nucleoside/nucleotide-like compounds and combination therapies) and host-directed broad-spectrum antivirals and antibacterials such as molecules that target host signaling pathways, are involved in entry and replication, epigenetic modifications in the host, and modulation of host response.
solicitation_url: https://www.medcbrn.org/solicitations/